Search Results 281-290 of 17068 for monoclonal antibody

  1. Science Saturday: Collaborative study discovers new disease behind patient's recurring blood clots

    It occurs when an individual produces monoclonal antibodies (mAbs) to platelet factor 4 (PF4) leading to blood clots and low platelet counts. "MGTS is a ...

  2. Pertuzumab (intravenous route) - Mayo Clinic

    The HER2 protein is produced by some breast tumors. Pertuzumab is a monoclonal antibody that interferes with the growth of this protein, which is eventually ...

  3. Chronic Myelogenous Leukemia Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody ...

  4. Mayo experts encouraged by authorization of first pill to treat COVID-19

    And unlike monoclonal antibodies, it should retain efficacy against variants," says Dr. Priya Sampathkumar, a Mayo Clinic infectious diseases specialist ...

  5. Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as alemtuzumab, can bind to and kill malignant lymphocytes. PURPOSE: This phase I/II trial is studying the side effects and best ...

  6. Crohn's disease - Diagnosis and treatment - Mayo Clinic

    Risankizumab also is a monoclonal antibody. This medicine acts against a molecule known as interleukin-23. Risankizumab was recently approved for treating ...

  7. Dostarlimab-gxly (intravenous route) - Mayo Clinic

    Dostarlimab-gxly is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or ...

  8. Mayo Clinic Uses New Approach to Reverse Multiple Sclerosis in Mice Models

    The monoclonal antibodies used in earlier research are large and complex, but were shown to promote both cell signaling and remyelination of central nervous ...

  9. Three new high-tech tools for state scientists from Minnesota Partnership - Mayo Clinic News Network

    D., Mayo Clinic; Claudia Neuhauser, Ph.D., University of Minnesota. Antibody phage display for monoclonal antibodies. Antibodies are identified and used not ...

  10. Vinorelbine Tartrate and Cyclophosphamide in Combination with Bevacizumab or Temsirolimus in Treating Patients with Recurrent or Refractory Rhabdomyosarcoma - Mayo Clinic

    Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. ... 3 half-lives (or 6 weeks) must have elapsed since previous monoclonal ...